MarkHolodniyMD
Infectious Disease • Palo Alto, CAHIV/AIDS Medicine, Microbiology
Professor of Medicine Stanford University
Dr. Holodniy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3801 Miranda Ave
# Mail
Palo Alto, CA 94304Phone+1 650-852-3408Fax+1 650-858-3978
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 1988 - 1991
University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 1985 - 1988
Northwestern University The Feinberg School of MedicineClass of 1985
Certifications & Licensure
CA State Medical License 1987 - 2026
AZ State Medical License 1986 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- American Academy of HIV MedicineHIV Medicine
- American Board of Internal MedicineInfectious Diseases
- American Board of Internal MedicineInfectious Diseases
Awards, Honors, & Recognition
- Fellow (FIDSA) Infectious Diseases Society of America, 2005
- Fellow (FSHEA) Society for Healthcare Epidemiology of America, 2005
- Fellow (FACP) American College of Physicians, 1995
Clinical Trials
- Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics Start of enrollment: 2018 Jan 22
- Adaptive COVID-19 Treatment Trial (ACTT) Start of enrollment: 2020 Feb 21
- Adaptive COVID-19 Treatment Trial 2 (ACTT-2) Start of enrollment: 2020 May 08
- Join now to see all
Publications & Presentations
PubMed
- 257 citationsPhylogeny of Zika Virus in Western Hemisphere, 2015.Robert S. Lanciotti, Amy J. Lambert, Mark Holodniy, Sonia Saavedra, Leticia del Carmen Castillo Signor
Emerging Infectious Diseases. 2016-05-01 - 154 citationsNew protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis.Shan Liu, Lauren E. Cipriano, Mark Holodniy, Douglas K Owens, Jeremy D. Goldhaber-Fiebert
Annals of Internal Medicine. 2012-02-21 - 25 citationsClinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy.Norah A. Terrault, Jean-Michel Pawlotsky, John G. McHutchison, Frederick A. Anderson, Krajden M
Journal of Viral Hepatitis. 2005-09-01
Press Mentions
Highly Selective Retrieval of Accurate DNA Utilizing a Pool of in Situ-Replicated DNA from Multiple Next-Generation Sequencing PlatformsApril 20th, 2018
AmpliPhi to Collaborate with the U.S. Department of Veterans Affairs on Expanded Access for Investigational Bacteriophage Therapeutics AB-SA01 and AB-PA01March 13th, 2018
Committees
- Member, IDSA Diagnostics Committee 2017 - 2019
Professional Memberships
- Fellow
- Fellow
- Society for Healthcare Epidemiology of AmericaFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
